Stockreport
Lexicon Pharmaceuticals' (LXRX) CEO Lonnel Coats on Q1 2018 Results - Earnings Call Transcript [Seeking Alpha]
Last lexicon pharmaceuticals, inc earnings: 11/1 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations: lexpharma.com/investors
PDF
Lexicon Pharmaceuticals' (LXRX) CEO Lonnel Coats on Q1 2018 Results - Earnings Call Transcript
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | LXRX | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
LXRX alerts
LXRX alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LXRX alerts
High impacting Lexicon Pharmaceuticals, Inc news events
Weekly update
A roundup of the hottest topics
LXRX
NEWS
NEWS
- Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating.[MarketBeat]
- RM LAW Announces Class Action Lawsuit Against Lexicon Pharmaceuticals, Inc.[PR Newswire]
- LEXICON INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Lexicon Pharmaceuticals, Inc. To Contact The Firm[PR Newswire]
- Robbins Arroyo LLP: Lexicon Pharmaceuticals, Inc. (LXRX) Misled Shareholders According to a Recently Filed Class Action[Business Wire]
- Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Lexicon Pharmaceuticals, Inc.[Business Wire]
- More
LXRX
SEC Filings
SEC Filings
- 2/15/19 - Form PRE
- 2/14/19 - Form SC
- 2/13/19 - Form SC
- LXRX's page on the SEC website
- More